Literature DB >> 7797266

Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis.

M A Gonzalez-Gay1, E Zanelli, C J Krco, G H Nabozny, J Hanson, M M Griffiths, H S Luthra, C S David.   

Abstract

Collagen-induced arthritis (CIA) is an animal model of auto immune polyarthritis, sharing similarities with rheumatoid arthritis (RA). Paradoxally, susceptibility to mouse CIA is controlled by the H2A loci (DQ homologous) while RA is linked to HLA.DR genes (H2E homologous). We recently showed that the E beta d molecule prevents CIA development in susceptible H2q mice. We addressed the question of whether H2Eb polymorphism will influence CIA incidence as HLA.DRB1 polymorphism does in RA. In F1 mice, only H2Ebd and H2Ebs molecules showed protection. Using recombinant B10.RDD (Ebd/b) mice, we found that CIA protection was mediated by the first domain of the E beta d molecule. Using peptides covering the third hypervariable region of the E beta chain, we found a perfect correlation between presentation of E beta peptides by the H2Aq molecule and protection on CIA. Therefore, the mechanism by which H2Eb protects against CIA seems to rely on the affinity of E beta peptides for the H2Aq molecule.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797266     DOI: 10.1007/bf00164985

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  35 in total

1.  Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice.

Authors:  R Holmdahl; M Karlsson; M E Andersson; L Rask; L Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Molecular analysis and repair of a defective Ef alpha gene.

Authors:  K A Donovan; S K Singh; C S David; L R Pease
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

3.  Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.

Authors:  T Lund; L O'Reilly; P Hutchings; O Kanagawa; E Simpson; R Gravely; P Chandler; J Dyson; J K Picard; A Edwards
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

4.  Tolerance to a self-peptide from the third hypervariable region of HLA DRB1*0401 in rheumatoid arthritis patients and normal subjects.

Authors:  S Salvat; I Auger; L Rochelle; A Begovich; L Geburher; A Sette; J Roudier
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

Review 5.  Population genetics of rheumatoid arthritis.

Authors:  W Ollier; W Thomson
Journal:  Rheum Dis Clin North Am       Date:  1992-11       Impact factor: 2.670

6.  Determination of tolerance to self E alpha peptides by clonal elimination of H-2E reactive T cells and antigen presentation by H-2A molecules.

Authors:  C J Krco; T G Beito; C S David
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

7.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

8.  Monoclonal antibody against an Ir gene product?

Authors:  E A Lerner; L A Matis; C A Janeway; P P Jones; R H Schwartz; D B Murphy
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

9.  Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E alpha chain.

Authors:  R Merino; M Iwamoto; L Fossati; P Muniesa; K Araki; S Takahashi; J Huarte; K Yamamura; J D Vassalli; S Izui
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

10.  Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis.

Authors:  M A Gonzalez-Gay; G H Nabozny; M J Bull; E Zanelli; J Douhan; M M Griffiths; L H Glimcher; H S Luthra; C S David
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  8 in total

1.  Sequence analysis of MHC class II Eb cDNAs from H2r and H2p haplotypes.

Authors:  B Y Wei; H Cao; S Pan; C S David
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 2.  HLA transgenic mice as humanized mouse models of disease and immunity.

Authors:  V Taneja; C S David
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

3.  H2-A polymorphism contributes to H2-Ebeta-mediated protection in collagen-induced arthritis.

Authors:  M A Gonzalez-Gay; E Zanelli; S D Khare; C J Krco; M M Griffiths; H S Luthra; C S David
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis.

Authors:  E Zanelli; C J Krco; J M Baisch; S Cheng; C S David
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Demonstration of three DRB loci in a domestic horse family.

Authors:  D G Fraser; E Bailey
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

6.  Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects.

Authors:  M Baumgart; V Moos; D Schuhbauer; B Müller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

7.  Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination.

Authors:  Danqing Zhang; Keishi Fujio; Yi Jiang; Jingyuan Zhao; Norihiro Tada; Katsuko Sudo; Hiromichi Tsurui; Kazuhiro Nakamura; Kazuhiko Yamamoto; Hiroyuki Nishimura; Toshikazu Shira; Sachiko Hirose
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-10       Impact factor: 11.205

8.  Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus.

Authors:  A L Rothman; I Kurane; F A Ennis
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.